West Hartford, Connecticut – A recent study suggests that the inexpensive diabetes drug, Metformin, may hold the key to a longer and healthier life. Metformin, commonly used to lower blood sugar levels and manage type 2 diabetes, is believed to have additional benefits such as protecting against cancer, cognitive decline, and heart disease due to its anti-inflammatory properties.

According to NPR, scientists are conducting a clinical trial known as The TAME Trial to determine if Metformin can slow down aging and prevent diseases in older healthy adults. The trial aims to enroll 3,000 individuals aged between 65 and 79 over the course of six years.

One couple, attorney Michael Cantor and West Hartford Mayor Shari Cantor, both in their mid-60s, credit Metformin for improving their quality of life. Michael started taking the drug a decade ago to manage his weight and blood sugar, while Shari began taking it during the pandemic after hearing it could help prevent infections.

Researchers like Steven Austad, a senior scientific advisor at the American Federation for Aging Research, acknowledge the potential of Metformin in increasing lifespan based on existing evidence. Studies have suggested that the drug may reduce the risk of various cancers and lower the risk of dementia and cardiovascular issues in individuals with type 2 diabetes who take Metformin.

Despite the promising benefits of Metformin, researchers emphasize the need for a clinical trial to establish concrete evidence. While some individuals have reported minor side effects like difficulty in building new muscle and vitamin B deficiency, the overall outlook on Metformin’s potential impact on aging and disease prevention remains positive.

Going forward, the future of Metformin and its role in promoting healthy aging and preventing diseases continues to be a topic of interest among researchers and individuals seeking to enhance their longevity and well-being.